SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC grew its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 34.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 152,430 shares of the exchange traded fund’s stock after acquiring an additional 39,190 shares during the quarter. Commonwealth Equity Services LLC’s holdings in SPDR S&P Biotech ETF were worth $13,728,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of XBI. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after purchasing an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd acquired a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at about $141,284,000. Proficio Capital Partners LLC grew its stake in shares of SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after buying an additional 911,686 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $55,529,000. Finally, J.Safra Asset Management Corp raised its position in shares of SPDR S&P Biotech ETF by 461.6% during the 4th quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock valued at $26,293,000 after buying an additional 240,415 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $88.29 on Tuesday. The stock has a 50 day moving average of $89.98 and a 200 day moving average of $94.69. The firm has a market capitalization of $5.72 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.